Samuel Álvarez-Almazán, MSc., PhD. He obtained the titles of Chemical Pharmacist (2012, Universidad Nacional Autónoma de México (UNAM)), Master of Science in Pharmacology (2016), and Philosophy Degree in Medicine Research (2020) from the Instituto Politécnico Nacional (IPN). He currently works as Professor-Researcher at the Facultad de Estudios Superiores Cuautitlán, UNAM. He belongs to the National System of Researchers from Consejo Nacional de Ciencia y Tecnología. He focuses on the study of chronic degenerative diseases. His research field is on diabetes, metabolic syndrome, cancer, synthesis, and the evaluation of compounds in vivo, in vitro, and ex vivo. Additionally, he is searching for biological applications for chitosan nanoparticles.
Research Keywords & Expertise
Diabetes
diabetes and cancer
PPAR receptors
Diabetes and diabetes ...
Signaling crosstalk
Short Biography
Samuel Álvarez-Almazán, MSc., PhD. He obtained the titles of Chemical Pharmacist (2012, Universidad Nacional Autónoma de México (UNAM)), Master of Science in Pharmacology (2016), and Philosophy Degree in Medicine Research (2020) from the Instituto Politécnico Nacional (IPN). He currently works as Professor-Researcher at the Facultad de Estudios Superiores Cuautitlán, UNAM. He belongs to the National System of Researchers from Consejo Nacional de Ciencia y Tecnología. He focuses on the study of chronic degenerative diseases. His research field is on diabetes, metabolic syndrome, cancer, synthesis, and the evaluation of compounds in vivo, in vitro, and ex vivo. Additionally, he is searching for biological applications for chitosan nanoparticles.
Honors and Awards
National Research candidate
Recognition as a researcher in development
National Council for Science and Technology (CONACyT, Mexico)
Well done!
